The new European public-private partnership aims to optimise and accelerate the development of treatments for rare and ultra-rare conditions and ultimately improve the lives of millions of patients across Europe and beyond.
The aim of the European survey on "Artificial Intelligence in Haematology: Knowledge and Perspectives" is to understand the current interest and perspectives of the healthcare community about the concept of AI and its applications in haematology.
On February 1, the European Haemophilia Consortium (EHC) marks the European Von Willebrand Disease (VWD) Awareness Day to raise awareness of the disease among the bleeding disorders community and the wider audience.
ERN-EuroBloodNet ERN-EuroBloodNet Hôpital St Louis / Université Paris 7 1 avenue Claude Vellefaux 75475 PARIS, France
ERN-EuroBloodNet is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are supported by the European Commission. For more information about the ERNs and the EU health strategy, please visit http://ec.europa.eu/health/ern
You are receiving this newsletter because you are part of the EuroBloodNet inventory of members or because you subscribed. Your data is gathered and processed in line with the General Data Protection Regulation and in accordance with EuroBloodNet Policy. You can unsubscribe any time by clicking below or contacting coordination@eurobloodnet.eu.
_1726154701.png)
_1738076264.jpg)
